Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chymotrypsin-like proteases are a class of serine or cysteine proteases characterized by their substrate specificity and structural features. They play essential roles in both physiological processes (such as digestion) and in the life cycles of certain viruses, including SARS-CoV-2. Human chymotrypsins are digestive enzymes that hydrolyze dietary proteins. Viral chymotrypsin-like proteases, such as the SARS-CoV-2 main protease (3CLpro or Mpro), are essential for processing viral polyproteins into functional units required for replication, making them attractive antiviral drug targets.
Inhibition of protease activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chymotrypsin-like Protease.